Pill MW - Search Results

1

Allergic rhinitis, asthma, and rhinosinusitis: diseases of the integrated airway.

Meltzer EO, Szwarcberg J, Pill MW. Meltzer EO, et al. Among authors: pill mw. J Manag Care Pharm. 2004 Jul-Aug;10(4):310-7. doi: 10.18553/jmcp.2004.10.4.310. J Manag Care Pharm. 2004. PMID: 15298529 Free PMC article. Review.

2

Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database.

Prescott JD, Factor S, Pill M, Levi GW. Prescott JD, et al. J Manag Care Pharm. 2007 Jan-Feb;13(1):44-52. doi: 10.18553/jmcp.2007.13.1.44. J Manag Care Pharm. 2007. PMID: 17269836 Free PMC article.

3

Applications of disease benchmarks and case presentations.

Pill MW. Pill MW. J Manag Care Pharm. 2005 Jan;11(1 Suppl A):S12-8. doi: 10.18553/jmcp.2005.11.s1-a.S12. J Manag Care Pharm. 2005. PMID: 15667243 Free PMC article.

4

Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis.

Menzin J, Caon C, Nichols C, White LA, Friedman M, Pill MW. Menzin J, et al. Among authors: pill mw. J Manag Care Pharm. 2013 Jan-Feb;19(1 Suppl A):S24-40. doi: 10.18553/jmcp.2013.19.s1.S24. J Manag Care Pharm. 2013. PMID: 23383731 Free PMC article. Review.

5

Perspectives for managed care organizations on the burden of multiple sclerosis and the cost-benefits of disease-modifying therapies.

Owens GM, Olvey EL, Skrepnek GH, Pill MW. Owens GM, et al. Among authors: pill mw. J Manag Care Pharm. 2013 Jan-Feb;19(1 Suppl A):S41-53. doi: 10.18553/jmcp.2013.19.s1.S41. J Manag Care Pharm. 2013. PMID: 23383732 Free PMC article. Review.

6

Intramuscular interferon beta-1a and evolving treatment options and outcomes measurement for MS: considerations for managed care.

Barnes CJ, Caon C, Foley JF, Friedman M, Menzin J, Nair KV, Nichols C, Olvey EL, Owens GM, Pill MW, Skrepnek GH, White LA, Zerkowski K. Barnes CJ, et al. Among authors: pill mw. J Manag Care Pharm. 2013 Jan-Feb;19(1 Suppl A):S1-53. doi: 10.18553/jmcp.2013.19.s1.1. J Manag Care Pharm. 2013. PMID: 23383730 Free PMC article. No abstract available.

7

Quantifying Differences in Health Care Consumption for the Management of Multiple Sclerosis Within Privately and Publicly Insured Health Care Programs.

Livingston T, Fay M, Iyer R, Wells W, Pill MW. Livingston T, et al. Among authors: pill mw. J Manag Care Spec Pharm. 2016 Dec;22(12):1385-1391. doi: 10.18553/jmcp.2016.22.12.1385. J Manag Care Spec Pharm. 2016. PMID: 27882831 Free PMC article.

8

A claims-based view of health care charges and utilization for commercially insured patients with osteoarthritis.

Dunn JD, Pill MW. Dunn JD, et al. Among authors: pill mw. Manag Care. 2009 Dec;18(12):44-50. Manag Care. 2009. PMID: 20088148

9

Quantifying the role of natalizumab in health and economic outcomes in multiple sclerosis.

Brandes DW, Shaya FT, Pill MW. Brandes DW, et al. Among authors: pill mw. Am J Manag Care. 2010 Jun;16(6 Suppl):S171-7. Am J Manag Care. 2010. PMID: 20615053 Free article. Review.

10

Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden.

Fredericks D, Norton JC, Atchison C, Schoenhaus R, Pill MW. Fredericks D, et al. Among authors: pill mw. Am J Manag Care. 2017 Apr;23(5 Suppl):S83-S92. Am J Manag Care. 2017. PMID: 28715903 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters